Paediatric inflammatory bowel disease
The Lancet Gastroenterology & Hepatology in conversation with
English - September 12, 2019 15:00 - 7 minutes - 5.13 MBLife Sciences Science Education gut intestines ibs ibd bowel medicine research Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Transplanting hepatitis C-infected hearts
Next Episode: Global burden of pancreatic cancer and colorectal cancer
Viktor Wintzell joins The Lancet Gastroenterology & Hepatology to discuss the risk of serious infection after use of tumour necrosis factor-α inhibitors in children with inflammatory bowel disease.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv